Methapharm Inc.
Brantford, ON
Company Overview
Methapharm is a privately held Canadian corporation engaged in the worldwide distribution and sale of finished dose pharmaceutical products. The company's HO is located in Brantford, Ontario and Methapharm has been operating since July 1995.
Methapharm's mission is to provide the international health care industry with quality niche products which fill market 'needs' not effectively serviced by larger pharmaceutical companies. This mission will be achieved through the sourcing and marketing of branded (and unbranded) products which no longer have the market 'critical mass' necessary to be of interest to multinational or large pharmaceutical companies.
The company's current principal business is methacholine, a bronchial provocation agent used to diagnose asthma patients. Methapharm exports to all corners of the world and has targeted several additional countries for regulatory approval by the millennium.
Recently, the company negotiated a licensing agreement with a major pharmaceutical company to takeover all rights to the leading and only FDA approved methacholine brand in the U. S. Provocholine.
Methapharm launched Provocholine in the U. S. under the Methapharm label in June 1998 and received it's NOC in February 1999 for Canada. It is the only methacholine chloride approved for human use in Canada and the USA.
Company Information
Physical Address
81 Sinclair Blvd.
Brantford, ON N3S 7X6
CA
Mailing Address
81 Sinclair Blvd.
Brantford, ON N3S 7X6
CA
Additional Details
Legal Name: Methapharm Inc.
Number of Employees: 6
CA
Contacts
Products
- Provocholine
NAICS Categories
Additional Information
414510
Australia, Austria, Colombia, Germany, Israel, Italy, Kuwait, Lithuania, South Africa, Spain, Thailand, United Kingdom, United States
Argentina, Brazil, France, Japan, New Zealand